Latest Organon News & Updates

See the latest news and media coverage for Organon. We track all announcements, press releases, and industry mentions in real time, all in one place.

Organon

Global healthcare company focused on women's health

organon.com

Headquarters: Jersey City, United States
Company type: Public company
Number of employees: 10,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Organon

In short: Organon agreed to an $11.75 billion acquisition by Sun Pharmaceutical Industries while expanding its biosimilar and women's health portfolio.

Company announcements

July 24 Organon

Organon presents new data for VTAMA cream in atopic dermatitis

Pooled Phase 3 data showed early, consistent improvements across pediatric age groups and adults, as early as week 2.

June 22 Organon

Organon completes licensing agreement for MIUDELLA IUD

The hormone-free copper IUD expands Organon's contraception portfolio and is FDA-approved for up to three years.

June 19 Organon

Organon has received regulatory approval in Japan

The approval is for a dysmenorrhea product, enhancing access and recognition of menstrual pain as an undertreated women's health issue, and credits Organon Japan's collaborative efforts.

June 10 Organon

Organon expands TOFIDENCE use to CRS and pediatric COVID-19

The FDA approved the biosimilar for treating CAR T-cell induced CRS and COVID-19 in patients aged 2 and older.

Media coverage

July 31 Yahoo Finance

Organon: Q2 Earnings Snapshot

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage...

July 31 BusinessLine

Sun Pharma on track to complete Organon transaction by Q4, says management

Sun Pharmaceutical Industries Ltd expects to complete its $11.75 billion acquisition of US-based Organon in the fourth quarter of financial year 2027, top management with...

July 24 Yahoo

Organon reports new findings from Vtama atopic dermatitis trials

The trial included data from 813 adults and children aged two years and older with moderate to severe atopic dermatitis.

July 17 Stock Titan

[8-K] Organon & Co. Reports Material Event | OGN 8-K Filing

Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.

Never miss news about Organon

Track Organon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.